23 results
8-K
EX-4.1
NRXP
NRX Pharmaceuticals Inc
19 Apr 24
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:10pm
10-K
2023 FY
EX-4.9
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
10-K
2023 FY
EX-4.8
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
8-K
EX-4.1
NRXP
NRX Pharmaceuticals Inc
28 Feb 24
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:09pm
8-K
EX-4.1
NRXP
NRX Pharmaceuticals Inc
1 Sep 23
NRx Pharmaceuticals Announces Definitive Purchase Agreement for Preferred Shares at $0.40 per share
4:48pm
8-K/A
EX-4.2
8qlmys8gmd uq
7 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
5:18pm
8-K/A
EX-4.1
8zs5av83 oo4
7 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
5:18pm
8-K
EX-4.2
9zr65bua9
6 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
4:27pm
8-K
EX-4.1
d4u276lptc7 tbm2
6 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
4:27pm
8-K/A
EX-4.1
d3wvo8r
14 Mar 23
NRx Pharmaceuticals Announces Close of $2.9 Million Registered Direct Offering
6:45am
8-K
EX-4.1
nqxs3gehc1edq
9 Mar 23
NRx Pharmaceuticals Announces Close of $2.9 Million Registered Direct Offering
8:46am
8-K
EX-4.3
zey502vmein7wycmjoh
22 Nov 17
Big Rock Partners Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
12:00am
8-K
EX-4.1
qr1tqf8w q6
22 Nov 17
Big Rock Partners Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
12:00am
8-K
EX-4.2
1ryg6b
22 Nov 17
Big Rock Partners Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
12:00am
S-1/A
EX-4.1
f9trmkcn4vq4t7
14 Nov 17
IPO registration (amended)
12:00am
S-1/A
EX-4.7
ck3que8pv
14 Nov 17
IPO registration (amended)
12:00am
S-1/A
EX-4.5
ykc2m4 w6
14 Nov 17
IPO registration (amended)
12:00am
S-1/A
EX-4.6
tovxi
14 Nov 17
IPO registration (amended)
12:00am